Показано 0 из 0
Дата |
---|
17:02 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.13
|
1.15
|
1.14
|
1.12
|
1.14
|
1.14
|
|
|
12 416.42
|
83.00
|
1.15
|
1.20
|
1.12
|
1.10
|
1.16
|
1.14
|
|
|
19 764.16
|
150.00
|
1.10
|
1.15
|
1.145
|
1.11
|
1.18
|
1.13
|
|
|
44 505.61
|
199.00
|
1.17
|
1.20
|
1.15
|
1.10
|
1.19
|
1.15
|
|
|
41 087.14
|
229.00
|
1.11
|
1.17
|
1.12
|
1.09
|
1.17
|
1.15
|
|
|
39 705.07
|
269.00
|
1.13
|
1.18
|
1.21
|
1.135
|
1.22
|
1.135
|
|
|
34 284.20
|
236.00
|
1.21
|
1.25
|
1.22
|
1.20
|
1.25
|
1.23
|
|
|
41 772.02
|
257.00
|
1.23
|
1.28
|
1.14
|
1.12
|
1.30
|
1.25
|
|
|
108 726.59
|
623.00
|
1.20
|
1.26
|
1.60
|
1.07
|
1.60
|
1.24
|
|
|
2 596 493.37
|
13 670.00
|
1.42
|
1.43
|
1.84
|
1.43
|
3.00
|
1.43
|
|
|
10 816 023.02
|
29 067.00
|
TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.